In Vitro Studies in Cold Agglutinin Disease


About this study

The purpose of this study is to assess antibody activity IN vitro in cold agglutinin disease (CAD) patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  1. Willing to give a blood sample
  2. Ability to provide informed consent
  3. Ability to complete all aspects of this trial
  4. At least 18 years of age
  5. Have cold agglutin disease with anemia

Exclusion Criteria: 

  • None

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Morie Gertz, M.D.

Closed for enrollment

Contact information:

Katrina Croghan CCRP

(507) 538-1866

More information


Publications are currently not available